Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4649015
Max Phase: Preclinical
Molecular Formula: C54H68N16O2
Molecular Weight: 973.25
Molecule Type: Unknown
Associated Items:
ID: ALA4649015
Max Phase: Preclinical
Molecular Formula: C54H68N16O2
Molecular Weight: 973.25
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CN1CCN(c2ccc3nc(-c4ccc5nc(CNC(=O)CCCCN6CCN(CCCCC(=O)NCc7nc8ccc(-c9nc%10ccc(N%11CCN(C)CC%11)cc%10[nH]9)cc8[nH]7)CC6)[nH]c5c4)[nH]c3c2)CC1
Standard InChI: InChI=1S/C54H68N16O2/c1-65-19-27-69(28-20-65)39-11-15-43-47(33-39)63-53(61-43)37-9-13-41-45(31-37)59-49(57-41)35-55-51(71)7-3-5-17-67-23-25-68(26-24-67)18-6-4-8-52(72)56-36-50-58-42-14-10-38(32-46(42)60-50)54-62-44-16-12-40(34-48(44)64-54)70-29-21-66(2)22-30-70/h9-16,31-34H,3-8,17-30,35-36H2,1-2H3,(H,55,71)(H,56,72)(H,57,59)(H,58,60)(H,61,63)(H,62,64)
Standard InChI Key: FQUSDFFQNKXARJ-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 973.25 | Molecular Weight (Monoisotopic): 972.5711 | AlogP: 5.92 | #Rotatable Bonds: 18 |
Polar Surface Area: 192.36 | Molecular Species: NEUTRAL | HBA: 12 | HBD: 6 |
#RO5 Violations: 4 | HBA (Lipinski): 18 | HBD (Lipinski): 6 | #RO5 Violations (Lipinski): 4 |
CX Acidic pKa: 10.78 | CX Basic pKa: 8.45 | CX LogP: 4.47 | CX LogD: 2.45 |
Aromatic Rings: 8 | Heavy Atoms: 72 | QED Weighted: 0.06 | Np Likeness Score: -0.78 |
1. Koval VS, Arutyunyan AF, Salyanov VI, Kostyukov AA, Melkina OE, Zavilgelsky GB, Klimova RR, Kushch AA, Korolev SP, Agapkina YY, Gottikh MB, Vaiman AV, Rybalkina EY, Susova OY, Zhuze AL.. (2020) DNA sequence-specific ligands. XVIII. Synthesis, physico-chemical properties; genetic, virological, and biochemical studies of fluorescent dimeric bisbenzimidazoles DBPA(n)., 28 (7): [PMID:32089391] [10.1016/j.bmc.2020.115378] |
Source(1):